Publication | Closed Access

Integrating Epidermal Growth Factor Receptor Assay With Clinical Parameters Improves Risk Classification for Relapse and Survival in Head-and-Neck Squamous Cell Carcinoma

MedicinePathologyHead And Neck CancerDermatologyCancer TreatmentNeck OncologyOncologyRadiation OncologyTumor MicroenvironmentCancer ResearchCancer GrowthSkin Cancer